New hope for advanced cancers: DSB2455 enters human trials
Disease control
Recruiting now
This early-phase trial tests a new drug called DSB2455 in adults with advanced cancers that have a specific DNA repair problem. The main goals are to find a safe dose and see if the drug can shrink tumors. About 90 participants will take part in this study across multiple centers…
Phase: PHASE1 • Sponsor: Duke Street Bio Ltd • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC